- Corporate Officers - S
- Smith Robin L
Insider Trading History of Smith Robin L
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Smith Robin L since 2006.
This trader's CIK number is 1365035.
At the time of last reporting, Smith Robin L was the Director of Sorrento Therapeutics, Inc.. (stock ticker symbol SRNE).
Also see all insider trading activities at Sorrento Therapeutics, Inc..
Note that in the past
Smith Robin L also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Servicesource International, Inc. (SREV) by Smith Robin L
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2020 | SREV | 50,000 | $85,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Emmaus Life Sciences, Inc. (MYAN) by Smith Robin L
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2016 | MYAN | 5,000 | $30,000 | 0 | $0 | 20,776 | $103,880 |
Yearly summary of insider trading at Sorrento Therapeutics, Inc. (SRNE) by Smith Robin L
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2021 | SRNE | 0 | $0 | 0 | $0 | 175,000 | $773,500 |
| 2020 | SRNE | 40,000 | $90,879 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Miragen Therapeutics, Inc. (SGNL) by Smith Robin L
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2017 | SGNL | 0 | $0 | 0 | $0 | 1,200 | $9,180 |
| 2015 | SGNL | 0 | $0 | 0 | $0 | 5,500 | $0 |
Yearly summary of insider trading at Caladrius Biosciences, Inc. ((NBS) by Smith Robin L
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2012 | (NBS | 36,000 | $24,839 | 0 | $0 | 0 | $0 |
| 2011 | (NBS | 56,136 | $37,754 | 0 | $0 | 0 | $0 |
| 2008 | (NBS | 16,667 | $0 | 0 | $0 | 0 | $0 |
| 2007 | (NBS | 423,300 | $54,450,000 | 0 | $0 | 0 | $0 |
| 2006 | (NBS | 500,000 | $22,000 | 0 | $0 | 0 | $0 |
Insider trading activities at 5 companies by Smith Robin L:
1. Servicesource International, Inc. (SREV)
2. Emmaus Life Sciences, Inc. (MYAN)
3. Sorrento Therapeutics, Inc. (SRNE)
4. Miragen Therapeutics, Inc. (SGNL)
5. Caladrius Biosciences, Inc. ((NBS)
Table 1. Insider trading of Servicesource International, Inc. (SREV) by Smith Robin L
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2020-05-20 | SREV | Buy | 50,000 | 1.70 | 85,000 |
Table 2. Insider trading of Emmaus Life Sciences, Inc. (MYAN) by Smith Robin L
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2016-12-13 | MYAN | Buy | 5,000 | 6.00 | 30,000 |
| 2016-09-21 | CNSO | Option Ex | 20,776 | 5.00 | 103,880 |
Table 3. Insider trading of Sorrento Therapeutics, Inc. (SRNE) by Smith Robin L
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2021-09-03 | SRNE | Option Ex | 175,000 | 4.42 | 773,500 |
| 2020-03-05 | SRNE | Buy | 40,000 | 2.27 | 90,879 |
Table 4. Insider trading of Miragen Therapeutics, Inc. (SGNL) by Smith Robin L
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2017-02-03 | SGNL | Option Ex | 1,200 | 7.65 | 9,180 |
| 2015-08-06 | SGNL | Option Ex | 4,125 | .00 | 0 |
| 2015-07-17 | SGNL | Option Ex | 1,375 | .00 | 0 |
Table 5. Insider trading of Caladrius Biosciences, Inc. ((NBS) by Smith Robin L
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2012-09-18 | (NBS | Buy | 36,000 | .69 | 24,839 |
| 2011-12-14 | NBS | Buy | 50,000 | .60 | 29,900 |
| 2011-02-28 | NBS | Buy | 6,136 | 1.28 | 7,854 |
| 2008-05-21 | NBS | Buy | 16,667 | .00 | 0 |
| 2007-08-14 | NBS | Buy | 3,300 | 16,500.00 | 54,450,000 |
| 2007-02-06 | NEOI | Buy | 20,000 | .00 | 0 |
| 2007-01-26 | NEOI | Buy | 200,000 | .00 | 0 |
| 2007-01-26 | NEOI | Buy | 200,000 | .00 | 0 |
| 2006-06-02 | PHSM | Buy | 500,000 | .04 | 22,000 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Smith Robin L
(Director of Sorrento Therapeutics, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.